Bottom line
What is EMSLX's expense ratio?
EMSLX's expense ratio is 1.23%, or about $123 a year on every $10,000 invested. That is more expensive than 67% of emerging markets funds we track (median 1.02%). Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Apr 30, 2026
EMSLX fee table
| Net expense ratio | 1.23% |
|---|---|
| Gross expense ratio | 2.1% |
| Management fee | 1% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.85% |
| Fee waiver / reimbursement | -0.87% |
Source: Fund prospectus fee table, filed Apr 30, 2026
What EMSLX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| EMSLX | $125 | $574 | $1,049 | $2,362 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.23% expense ratio costs roughly $66,800 in lost growth, versus about $56,400 for the median emerging markets fund (1.02%).
Cheaper alternatives to EMSLX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
| Fund | Expense ratio | Saves per year | Saves over 20 yrs* | Overlap |
|---|---|---|---|---|
| MXENX T. Rowe Price | 0.91% | $32 | $1,597 | 50% |
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.